"Designing Growth Strategies is in our DNA"

Liver Cancer Therapeutics Market Size, Share, Trends & COVID-19 Impact Analysis, By Therapy Type (Targeted Drug Therapy, Immunotherapy, and Chemotherapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI104657

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Liver Cancer –Key Regions/Country
    2. New Product Launch
    3. Pipeline Analysis
    4. Impact of COVID-19 on the Liver Cancer Treatment Market
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Liver Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Type
      1. Targeted Drug Therapy
      2. Immunotherapy
      3. Chemotherapy
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Liver Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Type
      1. Targeted Drug Therapy
      2. Immunotherapy
      3. Chemotherapy
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      2. Canada
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
  7. Europe Liver Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Type
      1. Targeted Drug Therapy
      2. Immunotherapy
      3. Chemotherapy
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K.
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      2. Germany
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      3. France
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      4. Spain
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      5. Italy
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      6. Scandinavia
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      7. Rest of Europe
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
  8. Asia Pacific Liver Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Type
      1. Targeted Drug Therapy
      2. Immunotherapy
      3. Chemotherapy
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      2. China
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      3. India
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      4. Australia
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      5. Southeast Asia
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      6. Rest of Asia Pacific
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
  9. Latin America Liver Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Type
      1. Targeted Drug Therapy
      2. Immunotherapy
      3. Chemotherapy
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      2. Mexico
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      3. Rest of Latin America
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
  10. Middle East & Africa Liver Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Type
      1. Targeted Drug Therapy
      2. Immunotherapy
      3. Chemotherapy
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    4. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      2. South Africa
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
      3. Rest of Middle East & Africa
        1. By Therapy Type
          1. Targeted Drug Therapy
          2. Immunotherapy
          3. Chemotherapy
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Therapy, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Bayer HealthCare Pharmaceuticals Inc.
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Bristol-Myers & Squibb Company
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Pfizer Inc.
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Exelixis, Inc.
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Merck Sharp & Dohme Corp.
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Eisai Inc.
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Eli Lilly and Company
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Other Prominent Players
        1. Overview
        2. Therapy
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  12. Strategic Recommendations
Read Less

Figure 01: Global Liver Cancer Treatment Market Value Share (%), by Region, 2019 & 2027
Figure 02: Global Liver Cancer Treatment Market Value Share (%), By Therapy Type, 2019 & 2027
Figure 03: Global Liver Cancer Treatment Market Forecast (USD Million), By Targeted Drug Therapy, 2016 -2027
Figure 04: Global Liver Cancer Treatment Market Forecast (USD Million), By Immunotherapy, 2016 -2027
Figure 05: Global Liver Cancer Treatment Market Forecast (USD Million), By Chemotherapy, 2016 -2027
Figure 06: Global Liver Cancer Treatment Market Value Share (%), By Distribution Channel, 2019 & 2027
Figure 07: Global Liver Cancer Treatment Market Forecast (USD Million), By Hospital Pharmacy, 2016 -2027
Figure 08: Global Liver Cancer Treatment Market Forecast (USD Million), By Retail Pharmacy, 2016 -2027
Figure 09: Global Liver Cancer Treatment Market Forecast (USD Million), By Online Pharmacy, 2016 -2027
Figure 10: North America Liver Cancer Treatment Market Value (USD Million), By Country, 2019 & 2027
Figure 11: North America Liver Cancer Treatment Market Value Share (%), By Country, 2019
Figure 12: North America Liver Cancer Treatment Market Value (USD Million), By Therapy Type, 2019 & 2027
Figure 13: North America Liver Cancer Treatment Market Value Share (%), By Therapy Type, 2019
Figure 14: North America Liver Cancer Treatment Market Value (USD Million), By Distribution Channel, 2019 & 2027
Figure 15: North America Liver Cancer Treatment Market Value Share (%), By Distribution Channel, 2019
Figure 16: Europe Liver Cancer Treatment Market Value (USD Million), By Country, 2019 & 2027
Figure 17: Europe Liver Cancer Treatment Market Value Share (%), By Country, 2019
Figure 18: Europe Liver Cancer Treatment Market Value (USD Million), By Therapy Type, 2019 & 2027
Figure 19: Europe Liver Cancer Treatment Market Value Share (%), By Therapy Type, 2019
Figure 20: Europe Liver Cancer Treatment Market Value (USD Million), By Distribution Channel, 2019 & 2027
Figure 21: Europe Liver Cancer Treatment Market Value Share (%), By Distribution Channel, 2019
Figure 22: Asia Pacific Liver Cancer Treatment Market Value (USD Million), By Country, 2019 & 2027
Figure 23: Asia Pacific Liver Cancer Treatment Market Value Share (%), By Country, 2019
Figure 24: Asia Pacific Liver Cancer Treatment Market Value (USD Million), By Therapy Type, 2019 & 2027
Figure 25: Asia Pacific Liver Cancer Treatment Market Value Share (%), By Therapy Type, 2019
Figure 26: Asia Pacific Liver Cancer Treatment Market Value (USD Million), By Distribution Channel, 2019 & 2027
Figure 27: Asia Pacific Liver Cancer Treatment Market Value Share (%), By Distribution Channel, 2019
Figure 28: Latin America Liver Cancer Treatment Market Value (USD Million), By Country, 2019 & 2027
Figure 29: Latin America Liver Cancer Treatment Market Value Share (%), By Country, 2019
Figure 30: Latin America Liver Cancer Treatment Market Value (USD Million), By Therapy Type, 2019 & 2027
Figure 31: Latin America Liver Cancer Treatment Market Value Share (%), By Therapy Type, 2019
Figure 32: Latin America Liver Cancer Treatment Market Value (USD Million), By Distribution Channel, 2019 & 2027
Figure 33: Latin America Liver Cancer Treatment Market Value Share (%), By Distribution Channel, 2019
Figure 34: Middle East & Africa Liver Cancer Treatment Market Value (USD Million), By Country, 2019 & 2027
Figure 35: Middle East & Africa Liver Cancer Treatment Market Value Share (%), By Country, 2019
Figure 36: Middle East & Africa Liver Cancer Treatment Market Value (USD Million), By Therapy Type, 2019 & 2027
Figure 37: Middle East & Africa Liver Cancer Treatment Market Value Share (%), By Therapy Type, 2019
Figure 38: Middle East & Africa Liver Cancer Treatment Market Value (USD Million), By Distribution Channel, 2019 & 2027
Figure 39: Middle East & Africa Liver Cancer Treatment Market Value Share (%), By Distribution Channel, 2019
Figure 40: Global Liver Cancer Treatment Market Revenue (%) Share Analysis by Key Players, 2019

Table 1:    Global Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Region, 2016–2027
Table 2:    Global Liver Cancer Treatment Market Revenue (USD Million) Forecast, By Therapy Type, 2016–2027
Table 3:    Global Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016–2027
Table 4:    North America Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Country, 2016–2027
Table 5:    North America Liver Cancer Treatment Market Revenue (USD Million) Forecast, By Therapy Type, 2016–2027
Table 6:    North America Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016–2027
Table 7: Europe Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Country, 2016–2027
Table 8: Europe Liver Cancer Treatment Market Revenue (USD Million) Forecast, By Therapy Type, 2016–2027
Table 9: Europe Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016–2027
Table 10: Asia Pacific Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Country, 2016–2027
Table 11: Asia Pacific Liver Cancer Treatment Market Revenue (USD Million) Forecast, By Therapy Type, 2016–2027
Table 12: Asia Pacific Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016–2027
Table 13: Latin America Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Country, 2016–2027
Table 14: Latin America Liver Cancer Treatment Market Revenue (USD Million) Forecast, By Therapy Type, 2016–2027
Table 15: Latin America Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016–2027
Table 16: Middle East & Africa Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Country, 2016–2027
Table 17: Middle East & Africa Liver Cancer Treatment Market Revenue (USD Million) Forecast, By Therapy Type, 2016–2027
Table 18: Middle East & Africa Liver Cancer Treatment Market Revenue (USD Million) Forecast, by Distribution Channel, 2016–2027

Liver Cancer Therapeutics Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports